Systemic Sclerosis

18-70

A Multicenter, Randomized, Parallel-group, Double-blind, Two-arm, Phase III Study to Evaluate the Safety and Efficacy of Anifrolumab Compared with Placebo in Male and Female Participants 18 to 70 Years of Age Inclusive with Systemic Sclerosis

GOUT

A Multi-Center Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Safety and Efficacy Study of Dapansutrile Tablets in Subjects with an Acute Gout Flare

Sjogren’s

Females ≥ 18 to ≤ 65

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the impact of Intravenous RSLV-132 in Participants with Primary Sjögren’s Syndrome (pSS) with Moderate to Severe Symptom Burden

Systemic Lupus Erythematosus

18 to ≤ 63

SELECT-SLE: A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Moderately to Severely Active SLE

Cutaneous Lupus Erythematosus

≥ 18

A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants with Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations

Chronic Lower Back Pain

≥ 18

A Prospective, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Combined with Hyaluronic Acid (HA) in Subjects with Moderate to Severe Chronic Low Back Pain

Psoriatic Arthritis

≥ 18

A Multi-Center, Randomized, Double-Blind, Placebo- and Active-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-Modifying Antirheumatic Drugs (LATITUDE-PsA-3001) A Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK- 279) in Subjects with Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-Modifying Antirheumatic Drugs

Osteoarthritis of the Knee

≥ 18 to 75 years

MPA-CARTISTEM-2023-01 Randomized, Prospective, Double Blinded, Multi-Center, Phase 3 Pivotal Clinical Trial to Compare Efficacy and Safety of CARTISTEM® and Surgical Comparator in Participants with Knee Osteoarthritis and Cartilage Lesions

Osteoarthritis of the Knee

≥ 18 to 75 years

Pre-Screening Registry for: MPA-CARTISTEM-2023-01 Randomized, Prospective, Double Blinded, Multi-Center, Phase 3 Pivotal Clinical Trial to Compare Efficacy and Safety of CARTISTEM® and Surgical Comparator in Participants with Knee Osteoarthritis and Cartilage Lesions

≥ 18 to 75 years

A Phase 3, Randomised, Double-Blind, Placebo-Controlled Multi-Centre Study to Evaluate the Treatment Effect of Pentosan Polysulfate Sodium Compared to Placebo in Participants with Knee Osteoarthritis Pain

Sjogren’s

≥ 18 to 75 years

A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study to Assess the EƯicacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Primary Sjogren’s Disease With Moderate to Severe Systemic Disease Activity